COMPLEMENT RECEPTOR C5AR1 CONTROLS LIVER MACROPHAGE OXIDATIVE-ANTIOXIDANT BALANCE AND INFLAMMASOME ASSEMBLY IN BILIARY ATRESIA

被引：0
|
作者：
Mourya, Reena [1 ]
Sudhakara, Pavithra [1 ]
Kang, Xiongbin [1 ]
Pandurangi, Sindhu [2 ]
Corbitt, Natasha [3 ]
Shivakumar, Pranavkumar [4 ]
机构：
[1] UT Southwestern Med Ctr, Dallas, TX USA
[2] UT Southwestern, Childrens Med Ctr Dallas, Dallas, TX USA
[3] UTSW, Childrens Med Ctr, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr, Dallas, TX USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2492
引用
收藏
页码：S1885 / S1885
页数：1
相关论文
共 39 条
  • [31] Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer
    Zhang, Puran
    Gu, Yun
    Wang, Jieti
    Lv, Kunpeng
    Lin, Chao
    Zhang, Heng
    Li, He
    He, Hongyong
    Li, Ruochen
    Liu, Hao
    Xu, Jiejie
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (01) : 224 - 237
  • [32] Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization
    Jiang, Keqing
    Lu, Shibang
    Li, Dongxiao
    Liu, Mingjiang
    Jin, Hu
    Lei, Biao
    Wang, Sifan
    Long, Kang
    He, Songqing
    Zhong, Fudi
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (09) : 894 - 907
  • [33] Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization
    Keqing Jiang
    Shibang Lu
    Dongxiao Li
    Mingjiang Liu
    Hu Jin
    Biao Lei
    Sifan Wang
    Kang Long
    Songqing He
    Fudi Zhong
    Journal of Gastroenterology, 2023, 58 : 894 - 907
  • [34] Complement Receptor C5aR1/CD88 and Dipeptidyl Peptidase-4/CD26 Define Distinct Hematopoietic Lineages of Dendritic Cells
    Nakano, Hideki
    Moran, Timothy P.
    Nakano, Keiko
    Gerrish, Kevin E.
    Bortner, Carl D.
    Cook, Donald N.
    JOURNAL OF IMMUNOLOGY, 2015, 194 (08): : 3808 - +
  • [35] First-in-human study with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients
    Ort, Marion
    Dingemanse, Jasper
    Hsin, Chih-hsuan
    Richard, Muriel
    Huehn, Eva
    Sabattini, Giancarlo
    van de Wetering, Jeroen
    Kornberger, Ruediger
    van den Anker, John
    Kaufmann, Priska
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 131 (02) : 114 - 128
  • [36] Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7-Wnt/b-catenin axis
    Shi, Lan
    Zhang, Shanshan
    Liu, Gan
    Nie, Zhengchao
    Ding, Pengsheng
    Chang, Wenjiao
    Dai, Yuanyuan
    Ma, Xiaoling
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (02)
  • [37] The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages
    Yu, Songlin
    Wang, Dan
    Huang, Lingmin
    Zhang, Yening
    Luo, Ruiheng
    Adah, Dickson
    Tang, Yiting
    Zhao, Kai
    Lu, Ben
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (21) : 8384 - 8394
  • [38] EFFECT OF COMPLEMENT FACTOR 5A RECEPTOR 1 (C5AR1) ANTAGONIST ACT-1014-6,470 ON THE CYTOCHROME P450 2C19 AND 3A4 SUBSTRATES OMEPRAZOLE AND MIDAZOLAM IN A COCKTAIL STUDY IN HEALTHY SUBJECTS
    Anliker-Ort, S. M.
    Berger, B.
    Kaufmann, P.
    Jana, L.
    van den Anker, J.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S61 - S62
  • [39] ASCPT Abstract PII-054: Effect of Complement Factor 5A Receptor 1 (C5AR1) Antagonist ACT-101-6450 on the Cytochrome P450 2C19 and 3A4 Substrates Omeprazole and Midazolam in a Cocktail Study in Healthy Subjects (vol 113, pg S5, 2023)
    Janu, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (03) : 721 - 721
1234